Ellington Management Group’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-12,800
| Closed | -$192K | – | 788 |
|
|
2017
Q3 | $192K | Sell |
12,800
-17,900
| -58% | -$269K | 0.03% | 528 |
|
|
2017
Q2 | $270K | Buy |
30,700
+17,000
| +124% | +$150K | 0.04% | 433 |
|
|
2017
Q1 | $71K | Buy |
+13,700
| New | +$71K | ﹤0.01% | 640 |
|
|
2016
Q4 | – | Sell |
-17,000
| Closed | -$79K | – | 765 |
|
|
2016
Q3 | $79K | Buy |
17,000
+1,900
| +13% | +$8.83K | 0.02% | 621 |
|
|
2016
Q2 | $87K | Sell |
15,100
-23,800
| -61% | -$137K | 0.12% | 221 |
|
|
2016
Q1 | $235K | Buy |
+38,900
| New | +$235K | 0.1% | 313 |
|
|
2015
Q2 | – | Sell |
-45,900
| Closed | -$720K | – | 858 |
|
|
2015
Q1 | $720K | Buy |
+45,900
| New | +$720K | 0.15% | 183 |
|
|
2014
Q3 | – | Sell |
-37,000
| Closed | -$565K | – | 455 |
|
|
2014
Q2 | $565K | Buy |
+37,000
| New | +$565K | 0.26% | 86 |
|